These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 29162831)
1. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Breglio AM; Rusheen AE; Shide ED; Fernandez KA; Spielbauer KK; McLachlin KM; Hall MD; Amable L; Cunningham LL Nat Commun; 2017 Nov; 8(1):1654. PubMed ID: 29162831 [TBL] [Abstract][Full Text] [Related]
2. Effect of cisplatin administration on the electrochemical composition of endolymph in the rat cochlea. Laurell G; Teixeira M; Sterkers O; Ferrary E Hear Res; 1995 Jul; 87(1-2):16-20. PubMed ID: 8567433 [TBL] [Abstract][Full Text] [Related]
3. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Sluyter S; Klis SF; de Groot JC; Smoorenburg GF Hear Res; 2003 Nov; 185(1-2):49-56. PubMed ID: 14599692 [TBL] [Abstract][Full Text] [Related]
4. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents. Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132 [TBL] [Abstract][Full Text] [Related]
5. Ototoxicity resulting from combined administration of cisplatin and gentamicin. Kohn S; Fradis M; Podoshin L; David YB; Zidan J; Robinson E; Nir I Laryngoscope; 1997 Mar; 107(3):407-8. PubMed ID: 9121325 [No Abstract] [Full Text] [Related]
6. Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin. Köppen C; Reifschneider O; Castanheira I; Sperling M; Karst U; Ciarimboli G Metallomics; 2015 Dec; 7(12):1595-603. PubMed ID: 26477751 [TBL] [Abstract][Full Text] [Related]
7. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Watanabe K; Inai S; Jinnouchi K; Bada S; Hess A; Michel O; Yagi T Anticancer Res; 2002; 22(6C):4081-5. PubMed ID: 12553036 [TBL] [Abstract][Full Text] [Related]
8. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492 [TBL] [Abstract][Full Text] [Related]
9. Allicin Protects against Cisplatin-Induced Stria Vascularis Damage: Possible Relation to Inhibition of Caspase-3 and PARP-1-AIF-Mediated Apoptotic Pathways. Cai J; Wu X; Li X; Ma C; Xu L; Guo X; Li J; Wang H; Han Y ORL J Otorhinolaryngol Relat Spec; 2019; 81(4):202-214. PubMed ID: 31340214 [TBL] [Abstract][Full Text] [Related]
10. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration. Sun C; Wang X; Chen D; Lin X; Yu D; Wu H Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701 [TBL] [Abstract][Full Text] [Related]
11. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Kohn S; Fradis M; Pratt H; Zidan J; Podoshin L; Robinson E; Nir I Laryngoscope; 1988 Aug; 98(8 Pt 1):865-71. PubMed ID: 3398664 [TBL] [Abstract][Full Text] [Related]
14. [Glycogenosis in cochlea of aging mice]. Ding D; Li M; Wang J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jan; 12(1):6-8. PubMed ID: 11189423 [TBL] [Abstract][Full Text] [Related]
15. The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach. Waissbluth S; Garnier D; Akinpelu OV; Salehi P; Daniel SJ Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1365-1374. PubMed ID: 27878588 [TBL] [Abstract][Full Text] [Related]
16. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss. Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102 [TBL] [Abstract][Full Text] [Related]
17. Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin. Sullivan MP; Morrow SJ; Goldstone DC; Hartinger CG Electrophoresis; 2019 Sep; 40(18-19):2329-2335. PubMed ID: 31087392 [TBL] [Abstract][Full Text] [Related]
18. The disruption and hyperpermeability of blood-labyrinth barrier mediates cisplatin-induced ototoxicity. Gu J; Tong L; Lin X; Chen Y; Wu H; Wang X; Yu D Toxicol Lett; 2022 Jan; 354():56-64. PubMed ID: 34757176 [TBL] [Abstract][Full Text] [Related]
19. Distribution and location of immunoreactive atrial natriuretic peptides in cochlear stria vascularis of guinea pig. Chen HX; Wang JL; Liu QC; Qiu JH Chin Med J (Engl); 1994 Jan; 107(1):53-6. PubMed ID: 8187573 [TBL] [Abstract][Full Text] [Related]
20. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig. Sepmeijer JW; Klis SF Hear Res; 2009 Jan; 247(1):34-9. PubMed ID: 18955125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]